Emergency Department-initiated Buprenorphine and Referral to Follow-up Addiction Care: A Program Description. Issue 2 (17th March 2022)

• Record Type: Journal Article
• Authors: Regan, Susan; Howard, Sydney; Powell, Elizabeth; Martin, Alister; Dutta, Sayon; Hayes, Bryan D.; White, Benjamin A.; Williamson, Dawn; Kehoe, Laura; Raja, Ali S.; Wakeman, Sarah E.
• Is Part Of: Journal of addiction medicine. Volume 16:Issue 2(2022)
• Page Start: 216
• Page End: 222
• Publication Date: 2022-03-17
• Subjects: Bridge Clinic -- buprenorphine -- emergency department -- opioid -- racism; Substance abuse -- Periodicals; Substance abuse -- Treatment -- Periodicals; Substance-Related Disorders -- Periodicals; 616.86005
• DOI: 10.1097/ADM.0000000000000875
• Languages: English
• ISSNs: 1932-0620

Abstract

Abstract : Introduction: Emergency department (ED) initiated opioid use disorder (OUD) care is effective; however, real-world predictors of patient engagement are lacking. Objective: This program evaluation examined predictors of ED-based OUD treatment and subsequent engagement. Method: Program evaluation in Boston, MA. Adult patients who met criteria for OUD during an ED visit in 2019 were included. Patients were included if a diagnosis of OUD or opioid-related overdose was associated with the ED visit or if they met previously validated criteria for OUD within the previous 12 months. We assessed predictors of ED-OUD treatment receipt and subsequent engagement, using Healthcare Effectiveness Data and Information Set definition of initial encounter within 14 days of discharge and either 2 subsequent encounters or a subsequent buprenorphine prescription within 34 days of the initial encounter. We used generalized estimating equations for panel data. Results: During 2019, 1946 patients met criteria for OUD. Referrals to Bridge Clinic were made for 207 (11%), buprenorphine initiated for 106 (5%), and home induction buprenorphine kits given to 56 (3%). Following ED discharge, 237 patients (12%) had a visit within 14 days, 122 (6%) had ≥2 additional visits, and 207 (11%) received a subsequent buprenorphine prescription. Young, White, male patients were most likely to receive ED-OUD care. Patients who received ED-OUD care were more likely to have subsequent treatment engagement (adjusted rate ratio: 2.30, 95% confidence intervals: 1.62–3.27). Referrals were made less often than predicted for Black (-49%) or Hispanic/Latinx (-25%) patients. Conclusions: Initiating treatment for OUD in the ED was associated with increased engagement in outpatient addiction care.